Moderna, Goldman Sachs, Tesla – 5 things you should know


Here are five things you should know for Wednesday, July 15:

1. – Increase of future shares in the progress of the vaccine

Stock futures rose Wednesday, receiving a boost from news that a candidate for the Moderna coronavirus vaccine (MRNA) – Get report it produced the desired immune response and a benchmark test will be launched later in July.

Contracts linked to the Dow Jones Industrial Average rose 316 points, S&P 500 futures gained 31 points and Nasdaq futures rose 75 points.

The vaccine, developed by Moderna and the US National Institutes of Health, produced antibodies in all patients evaluated in an initial safety trial. The data was published Tuesday night in the peer-reviewed New England Journal of Medicine.

.